| P50 | author | Sam Schulman | Q40806287 |
| P2093 | author name string | Sam Schulman | |
| P2860 | cites work | A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study | Q46487261 |
| | Pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--in rats and dogs | Q46820528 |
| | The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans | Q46897672 |
| | A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement | Q47300350 |
| | Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. | Q51027671 |
| | Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. | Q55044458 |
| | Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. | Q55044630 |
| | Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study | Q56680969 |
| | Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial | Q26248603 |
| | New anticoagulants for treatment of venous thromboembolism | Q28269942 |
| | A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement | Q28274872 |
| | Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 |
| | Oxazolidinones: a review | Q28373208 |
| | Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran | Q33973559 |
| | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor | Q34455896 |
| | BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study | Q34561970 |
| | Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement | Q34564159 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial | Q34607209 |
| | Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial | Q34754096 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty | Q34789112 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty | Q34789118 |
| | Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial | Q34789474 |
| | Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. | Q44114570 |
| | Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial | Q44672192 |
| | Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial | Q45258336 |
| | In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans | Q46131618 |
| P433 | issue | 6 | |
| P304 | page(s) | 613-620 | |
| P577 | publication date | 2009-08-10 | |
| P1433 | published in | Clinical and Applied Thrombosis-Hemostasis | Q5133805 |
| P1476 | title | Rivaroxaban in orthopedic surgery--a change of paradigm? | |
| P478 | volume | 15 | |